Comparison of Tolerability Between Two Allergy Drops

Hom, Milton M., OD, FAAO

Status and phase: Unknown; Phase 4

Conditions: Allergic Conjunctivitis

Treatments: Drug: alacaftadine and naphazoline HCl & pheniramine maleate

Study type: Interventional

Funder types: Industry

Identifiers

NCT01390961

IIT-000256

Details and patient eligibility

About

Comfort is compared between two allergy drops

Enrollment: 48 estimated patients

Sex: All

Ages: 18+ months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Between the ages of 18 and over inclusive.
• Males or females
• Patient is in generally good & stable overall health.
• Patient likely to comply with study guidelines & study visits.
• Informed consent signed.
• History of allergic conjunctivitis
• Current symptoms of allergic conjunctivitis assessed by the investigator

Exclusion criteria

• Corneal refractive surgery or contact lens wear within 6 months of this study.
• Current use of Restasis
• Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
• Pregnant or lactating women.
• Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind